E
Emily B. Sonnenblick
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 17
Citations - 230
Emily B. Sonnenblick is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Breast imaging & Mammography. The author has an hindex of 6, co-authored 13 publications receiving 161 citations. Previous affiliations of Emily B. Sonnenblick include Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
Breast Imaging of Transgender Individuals: A Review
TL;DR: Although not yet evidence-based, screening mammography is currently suggested for transgender women with risk factors, including those receiving hormone treatment over 5 years, including the risk for breast cancer in transgender individuals is still being defined.
Journal ArticleDOI
Breast Cancer in Male-to-Female Transsexuals: Use of Breast Imaging for Detection
K. Maglione,Laurie R. Margolies,Shabnam Jaffer,Janet Szabo,Hank Schmidt,Christina Weltz,Emily B. Sonnenblick +6 more
TL;DR: Screening for breast cancer in male-to-female transsexuals should be undertaken for those with additional risk factors (e.g., family history, BRCA2 mutation, Klinefelter syndrome) and should be available to those who desire screening, preferably in a clinical trial.
Journal ArticleDOI
Digital Breast Tomosynthesis Changes Management in Patients Seen at a Tertiary Care Breast Center
Laurie R. Margolies,A. Cohen,Emily B. Sonnenblick,John Mandeli,Paul H. Schmidt,Janet Szabo,Neesha Patel,George Hermann,Christina Weltz,Elisa Port +9 more
TL;DR: DBT increased cancer detection rate by 20% and decreased the recall rate in 8–25 patients and led to a doubling of the cancer Detection rate in recalled patients.
Journal ArticleDOI
Incremental Role of Mammography in the Evaluation of Gynecomastia in Men Who Have Undergone Chest CT
TL;DR: Men with clinical symptoms of gynecomastia do not need additional imaging with mammography to confirm the diagnosis if they have undergone recent cross-sectional imaging, and Mammography performed within 8 months of CT is unlikely to reveal cancer unless there is a suspicious clinical finding or a breast mass eccentric to the nipple.
Journal ArticleDOI
Cellular fibroadenoma on Core needle biopsy: management recommendations for the radiologist.
TL;DR: Larger mass size and increased histologic cellularity were associated with excision recommendation, but only clinical growth was associated with PT.